Table Detravenol n / 500 mg of 30 pieces + 30 pieces

$18.81

Table Detravenol n / 500 mg of 30 pieces + 30 pieces

Quantity:

SKU: 0178226557 Categories: , Tags: ,

Description

Composition
Active substance:
Rowan mikronizi- purified flavonoid fraction including .: diosmin (90%) – 450.000 mg; flavonoids based on hesperidin (10%) – 50,000 mg.
Excipients:
Kernel: gelatin – 13,500 mg Sodium carboxymethyl – 27,000 mg magnesium stearate – 6.500 mg Microcrystalline cellulose – to 650,000 mg.
Coating: Opadry II 85F240012 Pink – 20,000 mg: polyvinylalcohol – 8.000 mg macrogol 3350 – 4,876 mg, colorant Iron oxide red – 0.080 mg, dye yellow iron oxide – 0.044 mg talc – 2.960 mg of titanium dioxide – 4,040 mg.
Description:
Oval biconvex tablets, film-coated from pink to pale pink in color with scored on one side. The cross section shows two layers: core – from gray-brown to gray-yellow color interspersed with lighter and darker shades, and film coating.
Product form:
Tablets, film-coated 500 mg.
At 5, 10, 15 tablets in blisters of PVC film and aluminum foil printed patent.
30 tablets in banks for polyethylene terephthalate or polypropylene drugs for medicines, caps of the capped high-pressure polyethylene having a first opening control, or polypropylene caps System “push-turn” or caps of high density polyethylene with a first control opening.
One jar or 2/3/6, contour cell packages together with instructions for use placed in a cardboard box (pack).
Equipment is allowed to 2 or 3 cartons (packs) in multipacks (transport packaging) of paperboard for consumer packaging.
Contraindications
– Increased sensitivity to the drug;
– are breast-feeding period (application experience is limited).
Dosage
50 mg + 450 mg
Indications
Treatment of symptoms of chronic venous diseases (removal and relief of symptoms).
Therapy symptoms venous-lymphatic insufficiency:
– pain;
– spasms of the lower limbs;
– a feeling of heaviness and fullness in the legs;
– “tired” legs.
Therapy manifestations of venous-lymphatic insufficiency:
– edema of the lower extremities;
– trophic changes of the skin and subcutaneous tissue;
– venous trophic ulcers.
Symptomatic treatment of acute and chronic hemorrhoids.
Interaction with other drugs
Not mentioned.
It is necessary to inform the doctor about all the medicines you are taking.
Overdose
Overdose cases are not described.
If overdose occurs, seek immediate medical help!
pharmachologic effect
Pharmacological group:
venotoniziruyuschee and venoprotektornoe means.
Pharmacodynamics:
Combination hesperidin + diosmin has angioproteguoe and venotonic properties. It reduces the extensibility of the veins and venous stasis, in microcirculation – reduces the permeability of capillaries and increases their resistance, improves venous hemodynamics. It affects the following venous plethysmographic parameters: venous capacity, venous rastyazhi- bridges, time of venous emptying. Optimal effect is achieved when receiving 1000 mg.
The combination of diosmin + hesperidin improves venous tone by reducing the time of venous emptying. Patients with signs of pronounced microcirculatory disorders observed increase in capillary rezistent- Nost.
The combination of diosmin hesperidin + effective in treating chronic diseases of the lower limbs, as well as in the treatment of hemorrhoids.
Pharmacokinetics:
Preparation Detravenol advantageously derived through the intestine. Kidneys an average output of about 14% of the dose preparation.
half-life is 11 hours.
The drug undergoes active metabolism, which is confirmed by the presence of phenolic acids in the urine.
Pregnancy and breast-feeding
Pregnancy
Animal experiments did not reveal any teratogenic effects.
Until now there has been no reports of adverse effects when using the drug in pregnant women.
Lactation
Due to lack of data on the excretion of the drug in breast milk, breast-feeding women are not recommended to take the drug.
Effects on reproduction
Reproductive toxicity studies have not shown effects on reproductive function in rats of both sexes.
Conditions of supply of pharmacies
Available without prescription.
side effects
The frequency of side effects is defined according to the WHO classification
adverse events by frequency of occurrence: very often – more than 1/10, frequently – more than 1/100 and less than 1/10, infrequently – more and less than 1/100 to 1/1000, rarely – more and less than 1/1000 1/10000 very rarely – less than 1/10000, including isolated cases; unknown frequency a (determine adverse reaction frequency of occurrence of the available data is impossible).
Central nervous system: rarely – headache, dizziness, malaise.
Gastro-intestinal tract: often – diarrhea, dyspepsia, nausea, vomiting; rarely – colitis; unspecified frequency – abdominal pain.
Skin and subcutaneous adipose tissue: rare – skin rash, pruritus, urticaria; unspecified frequency – Vanny isolated swelling of the face, lips, eyelids; in exceptional cases – angioedema.
If you have marked side effects listed in the instructions, or they are compounded, or if you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
Before you start taking the drug Detravenol recommended prokonsultirovat- camping with your doctor.
During exacerbation of hemorrhoids Detravenol use of the drug does not replace specific treatment other anal disorders.
The duration of treatment should not exceed the time specified in the “Method of administration and dose.” In that case, if the symptoms do not disappear after the recommended course of treatment, should be examined by a proctologist, who will pick up further therapy.
In the presence of venous circulation disorders maximum treatment effect provided by a combination therapy with a healthy (balanced) manner life is desirable to avoid a long stay in the sun, prolonged exposure to the legs, as well as the recommended reduction of overweight. Hiking and, in some cases, wearing special stockings helps to improve blood circulation.
In the absence of reduction or weighting of symptoms consult a doctor!
Do not exceed the maximum term and recommended dose without approval from your doctor!
The effect on the ability to operate vehicles, machinery
The drug has no effect on ability to drive and use machines.
Storage conditions
At temperatures above 25 ° C.
Keep out of the reach of children.
Dosing and Administration
Inside.
The recommended dose for lymph-venous insufficiency tion – 2 tablets per day, preferably in the morning at mealtimes.
The duration of treatment may last several months (up to 12
months). In the case of recurrence of symptoms, on doctor’s advice, treatment can be repeated.
The recommended dose for acute hemorrhoid – 6 tablets per day (3 tablets morning and evening for 3 tablets) for 4 days, then 4 tablets per day (2 tablets in the morning and evening) during the next 3 days.
The recommended dose for chronic hemorrhoids – 2 tablets per day.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

OZONE BRANDS

There are no reviews yet.

Add your review